Form 8-K - Current report:
SEC Accession No. 0001193125-26-220638
Filing Date
2026-05-13
Accepted
2026-05-13 08:00:44
Documents
11
Period of Report
2026-05-13
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K tyra-20260513.htm   iXBRL 8-K 47808
2 EX-99.1 tyra-ex99_1.htm EX-99.1 198199
3 GRAPHIC img74818929_0.jpg GRAPHIC 343779
  Complete submission text file 0001193125-26-220638.txt   768512

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT tyra-20260513.xsd EX-101.SCH 24809
14 EXTRACTED XBRL INSTANCE DOCUMENT tyra-20260513_htm.xml XML 4701
Mailing Address 2656 STATE STREET CARLSBAD CA 92008
Business Address 2656 STATE STREET CARLSBAD CA 92008 (619) 728-4760
Tyra Biosciences, Inc. (Filer) CIK: 0001863127 (see all company filings)

EIN.: 831476348 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40800 | Film No.: 26970983
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)